Evolent Health Inc(EVH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -4.57 | Insider Own | 9.42% | Shs Outstand | 112.7M | Perf Week | -13.09% |
| Market Cap | 0.48B | Forward P/E | 11.94 | EPS next Y | 108.99% | Insider Trans | -0.61% | Shs Float | 102.4M | Perf Month | 21.78% |
| Enterprise Value | 1.31B | PEG | 0.16 | EPS next Q | 0.06 | Inst Own | 89.75% | Short Float | 11.62% | Perf Quarter | 37.54% |
| Income | -0.51B | P/S | 0.23 | EPS this Y | 89.21% | Inst Trans | -1.48% | Short Ratio | 4.57 | Perf Half Y | 13.33% |
| Sales | 2.10B | P/B | 1.25 | EPS next 5Y | 74.81% | ROA | -22.78% | Short Interest | 11.90M | Perf YTD | 6.25% |
| Book/sh | 3.4 | P/C | 3.46 | EPS past 3/5Y | -194.21% -5.21% | ROE | -78.95% | 52W High | -43.33% ($7.50) | Perf Year | -39.97% |
| Cash/sh | 1.23 | P/FCF | 19.74 | Sales past 3/5Y | 11.54% 15.2% | ROIC | -37.35% | 52W Low | 102.86% ($2.10) | Perf 3Y | -82.28% |
| Dividend Est. | - | EV/EBITDA | 14.9 | EPS Y/Y TTM | -184.71% | Gross Margin | 11.89% | Volatility(W/M) | 6.15% 6.69% | Perf 5Y | -85.48% |
| Dividend TTM | - | EV/Sales | 0.63 | Sales Y/Y TTM | -4.5% | Oper. Margin | -1.33% | ATR (14) | 0.27 | Perf 10Y | -79.91% |
| Dividend Ex-Date | - | Quick Ratio | 1.24 | EPS Q/Q | 42.84% | Profit Margin | -24.37% | RSI (14) | 47.8 | Recom | 1.43 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.24 | Sales Q/Q | 46.86% | SMA20 | -2.82% ($4.37) | Beta | 1.08 | Target Price | $5.75 |
| Payout | - | Debt/Eq | 2.53 | Earnings | 2026/11/5 | SMA50 | 1.1% ($4.2) | Rel Volume | 0.5 | Prev Close | $4.33 |
| Employees | 4200 | LT Debt/Eq | 2.53 | EPS/Sales Surpr. | 292.31% 9.17% | SMA200 | 9.9% ($3.87) | Avg Volume(3M) | 2.60M | Price | $4.25 |
| IPO | 2015/6/5 | Option/Short | Yes/Yes | Trades | 5558 | Volume | 1,302,471 | Change | -1.85% |
Evolent Health trades under the ticker EVH and is a U.S. healthcare technology and services company focused on value-based care. It provides care management and administrative solutions to payers and provider organizations across specialty areas such as oncology, cardiology, and musculoskeletal care. Its business model is built around a data-driven platform designed to reduce medical costs while simultaneously improving the quality of care.
Over the past 1 year, roughly in the middle
43% below its 1-year high.
Traded less than usual. That is 50% of its average volume.
Next earnings report: November 5
6 days to go.
EVH has weak earning power
Of every $100 in sales, $1.33 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +89.2% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $23. Peers typically go for $181.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -85.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 89.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #21 of 41 in the industry
Based on market cap of $481M.
WEAV#19 Weave Communications Inc $595M PER - 
NRC#20 NRC Health $520M PER 84.5 EVH#21 Evolent Health Inc $481M PER - 
CARL#22 Carlsmed Inc $431M PER - 
CTEV#23 Claritev Corp $407M PER - 
FAQ
What kind of company is EVH?
EVH belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of EVH?
The market cap of EVH is approximately $481M, ranking 3,198 within its sector.
What is the 52-week high and low for EVH?
EVH has recorded a 52-week high of $7.50 and a low of $2.10.
